Cipla gets final approval for Arformoterol Tartrate Inhalation Solution

23 Jun 2021 Evaluate

Cipla has received final approval for its Abbreviated New Drug Application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL from the United States Food and Drug Administration (US FDA). Cipla’s Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1344.95 -12.85 (-0.95%)
27-Feb-2026 12:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1762.30
Dr. Reddys Lab 1282.00
Cipla 1344.95
Zydus Lifesciences 918.75
Lupin 2304.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×